Overturn of Roe could make IVF more complicated, costly
By Ariana Eunjung Cha and Emily Wax-Thibodeaux,
The Washington Post
| 05. 11. 2022
After numerous rounds of in vitro fertilization (IVF), Genevieve Pearson Adair was excited to have 18 fertilized eggs. But it turned out that 14 of them have the Fragile X gene associated with intellectual and developmental disability. She has kept them frozen, unsure of what to do, hoping for a time when medical science could provide clearer answers.
But now, with the constitutional right to abortion hanging in the balance, she fears the right to determine their fate may be taken away from her.
A potential Supreme Court decision to overturn Roe v. Wade, amid the roiling landscape of state reproductive politics, is expected to open the door to state laws that give human embryos legal rights and protections — a possibility that would throw the fertility industry into upheaval and potentially limit choices would-be parents currently have about whether to use, store or discard genetic material that is part of the in vitro fertilization process.
“I and others are fearful of being labeled murderers for trying to do what is best not just for our children, but...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...